Primeri uporabe Activated factor v Angleški in njihovi prevodi v Slovenski
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Official/political
-
Programming
Activated Factor X converts prothrombin to thrombin.
Fondaparinux is a synthetic and selective inhibitor of activated Factor X(Xa).
It does not however inhibit thrombin(activated Factor II), and has no effects on platelets.
Activated factor IX, in combination with activated factor VIII, activates factor X.Activated factor X converts prothrombin into thrombin.
Fondaparinux does not inactivate thrombin(activated Factor II) and has no effects on platelets.
Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X.
Rivaroxaban does not inhibit thrombin(activated Factor II), and no effects on platelets have been demonstrated.
Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X.
Rivaroxaban does not inhibit thrombin(activated Factor II) and no effects on platelets have been demonstrated.
Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X.
Fondaparinux equipoise onlycycle does not inactivate thrombin(activated factor Pa) and has no effect on platelets.
Activated factor IX, in combination with activated factor VIII, activates factor X. This results ultimately in the conversion of prothrombin to thrombin.
When this factor is activated, in tandem with activated factor VIII, it activates factor X to convert prothrombin into thrombin.
Activated factor IX, in combination with activated factor VIII,activates factor X. This results ultimately in the conversion of prothrombin to thrombin.
In patients with inhibitor titres above 10 BU or with high anamnestic response, the use of(activated) prothrombin complex concentrate(PCC)or recombinant activated factor VII(rFVIIa) preparations has to be considered.
Activated factor IX, in combination with activated factor VIII,activates factor X. Activated factor X converts prothrombin into thrombin.
In patients with inhibitor titres above 10 BU or with high anamnestic response, the use of(activated) prothrombin complex concentrate(PCC)or recombinant activated factor VII(rFVIIa) preparations has to be considered.
Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X on phospholipid surfaces.
Activated Factor VIII acts as a co-factor for activated Factor IX, accelerating the conversion of Factor X to activated Factor X, which ultimately converts prothrombin into thrombin.
Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X. Activated factor X converts prothrombin into thrombin.
Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X. Activated factor X converts prothrombin into thrombin.
Activated factor VIII acts as a Cofactor for activated Factor IX, accelerating the conversion of Factor X to activated Factor X. Activated Factor X converts prothrombin to thrombin.
In addition to its direct effects, tasonermin modulates immune responses by inducing production of cytokines as well as low molecular weight mediators(prostaglandins,platelet activating factor).
Antagonic action on platelet activating factor(PAF), demonstrating pharmacological actions such as anti-thrombus, anti-myocardia ischemia, improving the microcirculation and prophylaxis of artery cirrhosis;
Thrombin plays a central role in the thrombotic process,acting to cleave fibrinogen into fibrin monomers and to activate Factor XIII to Factor XIIIa, allowing fibrin to develop a covalently cross- linked framework that stabilises the thrombus.